Earningsreport

Q2/2024 9/30/2023 EPS 88.780 ZacksConsensus 0.880 ActVsEst 87.900 - Beat

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors